CK
Colin Kleanthous
Ceased PSC Person with significant control at GLOX THERAPEUTICS LIMITED
Notified on 12th Apr 2023 · Ceased on 13th Apr 2023
Colin Kleanthous
Reports & checks
Buy a company report
Run an identity check
Natures of control
- Ownership of shares 25 to 50 percent
- Voting rights 25 to 50 percent